umu.sePublications
Change search
ReferencesLink to record
Permanent link

Direct link
Elevated Systemic Glutamic Acid Level in the Non-Obese Diabetic Mouse is Idd Linked and Induces Beta Cell Apoptosis
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Immunology/Immunchemistry.
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Immunology/Immunchemistry.
(English)Article in journal (Other academic) Submitted
National Category
Microbiology in the medical area
Identifiers
URN: urn:nbn:se:umu:diva-119451OAI: oai:DiVA.org:umu-119451DiVA: diva2:921015
Available from: 2016-04-19 Created: 2016-04-19 Last updated: 2016-04-20
In thesis
1. Metab-Immune analysis of the non-obese diabetic mouse
Open this publication in new window or tab >>Metab-Immune analysis of the non-obese diabetic mouse
2016 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Type 1A diabetes mellitus or T1D is a chronic disease characterized by T cell mediated destruction of the insulin producing β cells in the islets of Langerhans. The classical symptoms include high glucose levels in urine and blood, polyuria, and polydipsia. Complications associated with T1D include blindness, amputations, and end-stage renal disease, and premature death. The non-obese diabetic (NOD) mouse, first described in 1980, is widely used as a model organism for T1D. T1D disease in the NOD mouse shares a number of similarities to human T1D including dependence on genetic and environmental factors. More than 30 disease associated gene regions or loci (termed insulin dependent diabetes, or Idd, loci) have been associated with T1D development in NOD. For some of these Idds, the corresponding region in human has been linked to the development of T1D in human.

T1D, both in humans and mice, is recognized as a T cell mediated disease. However, many studies have shown the importance of both the metabolome and the immune system in the pathogenesis of the disease. Appearance of autoantibodies in the serum of patients is the first sign of pathogenesis. However, molecular and cellular events precede the immune attack on the β-cell immunity. It has been shown that patients who developed T1D have an altered metabolome prior to the appearance of autoantibodies. Although much is known about the pathogenesis of T1D, the contribution of the environment/immune factors triggering the disease is still to be revealed. 

In the present study both metabolic and immune deviations observed in the NOD mouse was analyzed. Serum metabolome analysis of the NOD mouse revealed striking resemblance to the human metabolic profile, with many metabolites in the TCA cycle significantly different from the non-diabetic control B6 mice. In addition, an increased level of glutamic acid was of the most distinguishing metabolite. A detailed bioinformatics analysis revealed various genes/enzymes to be present in the Idd regions. Compared to B6 mice, many of the genes correlated to the metabolic pathways, showed single nucleotide polymorphism (SNP), which can eventually affect the functionality of the protein. A genetic analysis of the increased glutamic acid revealed several Idd regions to be involved in this phenotype. The regions mapped in the genetic analysis harbor important enzymes and transporters related to glutamic acid. In-vitro islet culture with glutamic acid led to increased beta cell death indicating a toxic role of glutamic acid specifically towards insulin producing beta cells.

In the analysis of the immune system, B cells from NOD mice, which are known to express high levels of TACI, were stimulated with APRIL, a TACI ligand. This resulted in enhanced plasma cell differentiation accompanied with increased class switching and IgG production. NOD mice have previously been shown to react vigorously to T-dependent antigens upon immunization. In this study we confirmed this as NOD mice showed an enhanced and prolonged immune response to hen egg lysozyme. Thus, serum IgG levels were significantly increased in the NOD mice and were predominantly of the IgG1 subtype. Immunofluorescence analysis revealed increased number of germinal centers in the NOD mice. Transfer of purified B and T cells from NOD to an immune deficient mouse could reproduce the original phenotype as seen in the NOD mice.    

Collectively, this thesis has analyzed the metabolomics and immune deviations observed in the NOD mice.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2016. 62 p.
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 1777
Keyword
NOD mouse, Type 1 diabetes, B cells, glutamic acid, metabolomics
National Category
Immunology
Research subject
Immunology
Identifiers
urn:nbn:se:umu:diva-119444 (URN)978-91-7601-404-2 (ISBN)
Public defence
2016-05-13, A5_R0, Byg 6A, NUS, Umeå, 13:00 (English)
Opponent
Supervisors
Available from: 2016-04-21 Created: 2016-04-19 Last updated: 2016-04-20Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Banday, Viqar ShowkatLejon, Kristina
By organisation
Immunology/Immunchemistry
Microbiology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 45 hits
ReferencesLink to record
Permanent link

Direct link